(2S,3S,4S,5R,6S)-6-[2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carbonyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid - Names and Identifiers
(2S,3S,4S,5R,6S)-6-[2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carbonyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid - Physico-chemical Properties
Molecular Formula | C22H24N2O9S
|
Molar Mass | 492.5 |
Density | 1.52±0.1 g/cm3(Predicted) |
Melting Point | >120°C (dec.) |
Boling Point | 755.0±70.0 °C(Predicted) |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | White to Off-White |
pKa | 2?+-.0.70(Predicted) |
Storage Condition | Refrigerator, Under Inert Atmosphere |
(2S,3S,4S,5R,6S)-6-[2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carbonyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid - Introduction
Febuxostat acyl-β-D-glucoside (Febuxostat acyl-β-D-glucuronide) is a drug metabolite, a derivative of Febuxostat (a drug used to lower uric acid levels). Its structure contains a glucuronic acid group.
There is currently less information available on the properties of Febuxostat acyl-β-D-glucoside. According to research, it is a compound with high polarity and hydrophobicity.
As for the use, the specific use of Febuxostat acyl-β-D-glucoside in the pharmaceutical field has not been fully defined. However, drug metabolites are often studied for drug pharmacokinetics, including metabolic and excretory pathways.
Regarding the production method, Febuxostat acyl-β-D-glucoside is produced by chemical synthesis or biosynthesis.
Regarding safety information, due to its lack of research, the safety data of Febuxostat acyl-β-D-glucoside is also limited. Adequate clinical research and evaluation should be carried out in the design and use of any drug to ensure its safety and effectiveness.
Last Update:2024-04-09 21:54:55